ContractPulse
Awarded

Blood Group Genotyping for Sickle Cell and Thalassaemi

£140,671

services

Contract Details

Tender Value
£140,671
Stage
Awarded
Published
Awarded

Timeline

Start
Awarded
Disclosed
End

Description

The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

Related Contracts

Ref: d966c341-a622-49a0-b6f4-29dbbc3b93bf-862055 · Sourced from Contracts Finder

View source notice